Why the study?
Does the stress hyperglycemia ratio (SHR) predict short-term and long-term poor prognosis in patients with acute coronary syndrome undergoing DES implantation?
Does the stress hyperglycemia ratio (SHR) predict short-term and long-term poor prognosis in patients with acute coronary syndrome undergoing DES implantation?
Answers are grounded in this paper and cite their sources.
In ACS patients undergoing DES implantation, the stress hyperglycemia ratio has a non-linear association with adverse outcomes, identifying an optimal threshold of 0.78 for risk stratification.
There were U-shaped associations of SHR with MACCE rate and MACE rate at 2-year follow-ups and J-shaped associations of SHR with in-hospital cardiac death and MI and that at 2-year follow-up in ACS patients who underwent DES implantation, and the inflection point of SHR for poor prognosis was 0.78.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: